α‐Synuclein‐positive structures in association with diffuse neurofibrillary tangles with calcification

α−Synuclein is known to be a major constituent of the Lewy bodies (LBs) in Parkinson's disease (PD) and the neuronal and glial cytoplasmic inclusions (NCIs, GCIs) in multiple system atrophy. α−Synuclein‐positive inclusions such as LBs, NCIs and GCIs sometimes show colocalization with tau‐positive neurofilaments. Studies using α−synuclein immunohistochemistry have often found LBs in the amygdala of patients with familial or sporadic Alzheimer's disease (AD), as well as in patients with Down's syndrome and AD. However, no studies have reported α−synuclein‐positive structures in cases of diffuse neurofibrillary tangles with calcification (DNTC), which is characterized by numerous neurofibrillary tangles (NFTs) throughout the cerebral cortex but few, if any, senile plaques. We investigated the distribution of α−synuclein‐positive structures in two cases of DNTC: a 65‐year‐old woman (brain weight, 850 g) and a 75‐year‐old woman (brain weight, 800 g). In both cases, severe cerebral atrophy predominant in the temporal lobe was noted. Microscopically, α−synuclein‐positive intracytoplasmic inclusions and neurites were found in the superior temporal lobe (within the temporal pole), amygdala, parahippocampus, entorhinal cortex and insula, the regions most affected by the NFTs. α−Synuclein‐positive intracytoplasmic inclusions were rare or absent in other regions of the cerebral cortex and brainstem. This distribution pattern differs from that of PD or dementia with LBs. Our findings suggest that the accumulation pattern of α−synuclein is a pathological feature of DNTC, and that DNTC is associated with accumulation of both tau and α−synuclein.

[1]  G. Sobue,et al.  Widespread occurrence of argyrophilic glial inclusions in Parkinson's disease , 2001, Neuropathology and applied neurobiology.

[2]  G. Asano,et al.  α-Synuclein-positive structures in cases with sporadic Alzheimer’s disease: morphology and its relationship to tau aggregation , 2001, Brain Research.

[3]  T. Iwatsubo,et al.  Co-localization of α-synuclein and phosphorylated tau in neuronal and glial cytoplasmic inclusions in a patient with multiple system atrophy of long duration , 2001, Acta Neuropathologica.

[4]  S. Terada,et al.  Tau pathology in diffuse neurofibrillary tangles with calcification (DNTC): biochemical and immunohistochemical investigation , 2000, Neuroreport.

[5]  K. Arima,et al.  NACP/α-synuclein and tau constitute two distinctive subsets of filaments in the same neuronal inclusions in brains from a family of parkinsonism and dementia with Lewy bodies: double-immunolabeling fluorescence and electron microscopic studies , 2000, Acta Neuropathologica.

[6]  R. Hamilton,et al.  Lewy Bodies in Alzheimer's Disease: A Neuropathological Review of 145 Cases Using α‐Synuclein Immunohistochemistry , 2000, Brain pathology.

[7]  T. Iwatsubo,et al.  α‐Synuclein Inclusions in Amygdala in the Brains of Patients with the Parkinsonism‐Dementia Complex of Guam , 2000, Journal of neuropathology and experimental neurology.

[8]  W. Honer,et al.  α‐Synuclein Inclusions in Alzheimer and Lewy Body Diseases , 2000, Journal of neuropathology and experimental neurology.

[9]  K. Yang,et al.  An Autopsy Case of Pick's Disease. , 2000 .

[10]  Kazuko Aoto,et al.  Cellular co-localization of phosphorylated tau- and NACP/α-synuclein-epitopes in Lewy bodies in sporadic Parkinson's disease and in dementia with Lewy bodies , 1999, Brain Research.

[11]  P. Højrup,et al.  α-Synuclein Binds to Tau and Stimulates the Protein Kinase A-catalyzed Tau Phosphorylation of Serine Residues 262 and 356* , 1999, The Journal of Biological Chemistry.

[12]  M. Goedert Filamentous nerve cell inclusions in neurodegenerative diseases: tauopathies and alpha-synucleinopathies. , 1999, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[13]  K. Kosaka,et al.  Frequent coexistence of Lewy bodies and neurofibrillary tangles in the same neurons of patients with diffuse Lewy body disease , 1999, Neuroscience Letters.

[14]  J. Trojanowski,et al.  Antibodies to α‐synuclein detect Lewy bodies in many Down's syndrome brains with Alzheimer's disease , 1999, Annals of neurology.

[15]  J. Hardy,et al.  Genetic classification of primary neurodegenerative disease. , 1998, Science.

[16]  J Q Trojanowski,et al.  Lewy bodies contain altered alpha-synuclein in brains of many familial Alzheimer's disease patients with mutations in presenilin and amyloid precursor protein genes. , 1998, The American journal of pathology.

[17]  Shigeo Hirai,et al.  NACP/α-synuclein immunoreactivity in fibrillary components of neuronal and oligodendroglial cytoplasmic inclusions in the pontine nuclei in multiple system atrophy , 1998, Acta Neuropathologica.

[18]  K. Arima,et al.  Immunoelectron-microscopic demonstration of NACP/α-synuclein-epitopes on the filamentous component of Lewy bodies in Parkinson's disease and in dementia with Lewy bodies , 1998, Brain Research.

[19]  B. Winblad,et al.  Accumulation of cyclin-dependent kinase 5 (cdk5) in neurons with early stages of Alzheimer's disease neurofibrillary degeneration , 1998, Brain Research.

[20]  K. Jellinger,et al.  Senile Dementia with Tangles (Tangle Predominant Form of Senile Dementia) , 1998, Brain pathology.

[21]  J Q Trojanowski,et al.  Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies. , 1998, The American journal of pathology.

[22]  W. Honer,et al.  Abnormal accumulation of NACP/alpha-synuclein in neurodegenerative disorders. , 1998, The American journal of pathology.

[23]  Hitoshi Takahashi,et al.  NACP, a presynaptic protein, immunoreactivity in Lewy bodies in Parkinson's disease , 1997, Neuroscience Letters.

[24]  M. L. Schmidt,et al.  α-Synuclein in Lewy bodies , 1997, Nature.

[25]  Y. Hashizume,et al.  [An autopsied case of atypical presenile dementia which shows lobar atrophy, severe neurofibrillary tangles and calcification]. , 1997, Rinshō shinkeigaku Clinical neurology.

[26]  K. Imahori,et al.  Preferential labeling of Alzheimer neurofibrillary tangles with antisera for tau protein kinase (TPK) I/glycogen synthase kinase-3β and cyclin-dependent kinase 5, a component of TPK II , 1996, Acta Neuropathologica.

[27]  John A. Martin,et al.  Convergence of Lewy bodies and neurofibrillary tangles in amygdala neurons of Alzheimer’s disease and Lewy body disorders , 1996, Acta Neuropathologica.

[28]  J. Brion,et al.  Cortical and brainstem-type Lewy bodies are immunoreactive for the cyclin-dependent kinase 5. , 1995, The American journal of pathology.

[29]  K. Kosaka Diffuse neurofibrillary tangles with calcification: a new presenile dementia. , 1994, Journal of neurology, neurosurgery, and psychiatry.

[30]  H. Iwata,et al.  Non-Alzheimer non-Pick dementia with Fahr's syndrome. , 1992, Clinical neuropathology.

[31]  H. Ishino,et al.  [An autopsy case of Pick's disease with numerous neurofibrillary tangles (author's transl)]. , 1979, Rinshō shinkeigaku Clinical neurology.

[32]  A. Siddons A CASE OF PICK'S DISEASE , 1936 .